γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation.
about
Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations.NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma.Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays.Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance.Immune checkpoints and their inhibition in cancer and infectious diseases.The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer.Regional immunotherapy for liver and peritoneal metastases.Adoptive T cell therapy: An overview of obstacles and opportunities.Immunosurveillance by human γδ T lymphocytes: the emerging role of butyrophilins.Probing the Diversity of T Cell Dysfunction in Cancer.Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice.Immunosuppressive γδ T cells foster pancreatic carcinogenesis.Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer.CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma.Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis.Three distinct developmental pathways for adaptive and two IFN-γ-producing γδ T subsets in adult thymus.γδ T cells provide the early source of IFN-γ to aggravate lesions in spinal cord injury.IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population.Long-Lived Innate IL-17-Producing γ/δ T Cells Modulate Antimicrobial Epithelial Host Defense in the Colon.T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma.Gamma-delta (γδ) T cells: friend or foe in cancer development?Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment.BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC).Obesity exacerbates colitis-associated cancer via IL-6-regulated macrophage polarisation and CCL-20/CCR-6-mediated lymphocyte recruitment.Strategies for Increasing Pancreatic Tumor Immunogenicity.The role of γδ T cells in pancreatic cancer: what could this mean for the clinic?Butyrophilin3A proteins and Vγ9Vδ2 T cell activation.γδ T Cells: Unexpected Regulators of Cancer Development and Progression.γδT Cells Exacerbate Podocyte Injury via the CD28/B7-1-Phosphor-SRC Kinase Pathway.Immunotherapy With Human Gamma Delta T Cells-Synergistic Potential of Epigenetic Drugs?Innate γδT17 cells play a protective role in DSS-induced colitis via recruitment of Gr-1+CD11b+ myeloid suppressor cells.Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment.Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future OptionsKRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic CancerCXCR2 inhibition in pancreatic cancer: opportunities for immunotherapy?
P2860
Q33779875-D4717D09-4465-4CA0-8E6B-BDEF82DDF52EQ38820121-4B81022A-D31D-4ABC-B4D6-7AAB3C969BA5Q38839115-8259D67D-7F9B-41E4-82AE-A8A75E1EBA83Q38844576-242B979B-C73D-47E4-BEC5-EA53613663AEQ38845026-D330A042-76EF-4AF7-9C48-7D782D79080AQ39161005-94F8469A-B777-41D1-B0B7-3F27D1E341FDQ39178061-A758E44C-A377-4351-B05B-0B735E8ACFA0Q39235761-D214EAE5-EAFB-4DF8-A919-79A40A5E3A97Q39329364-C1EE1891-6B9A-4B2F-AC02-984766964D04Q39329596-562A7C58-D156-4615-9F71-208E83E8E9FEQ39397758-4EE404AE-9260-4902-BCC6-FCE4CA423799Q41098734-458818B2-5D47-4B8D-9969-D34E4841545BQ42314537-73E77935-B5F3-45B9-9848-77F1F5967778Q42357971-155B69D9-9F13-4BB0-8CDF-94151BF46444Q42660198-16C8A620-6CDD-428E-BD97-28E2422696D8Q42697314-1000D47A-AAE8-4E2A-A334-B03993856F7BQ43058997-1F9B942A-AF3B-43A0-8764-19D2888767F3Q47170298-2E68EB01-703B-42CB-896C-CAD14655F7A4Q47215543-39BD1E70-68F0-44CB-B22C-9CAABF5AB8D2Q47217155-1B107A33-1300-4238-831D-68DDD3C91A55Q47654916-229B19E6-4A7E-455A-9C6F-E92A46B10F6AQ47726063-D0939E7A-BF28-4006-A74C-929A74BB1A0EQ47742552-C82370C0-3474-413A-ACEB-1806D63D8305Q50133361-453431A1-182D-4A38-A999-E36FB8FAB6F2Q50420977-4BDB1FE0-8BDB-4B37-A523-6EC16061F768Q52562781-1C13EBE6-F41F-4AD6-AE69-1E180296B694Q52691832-73424963-FAFA-4A49-83D3-4135F7960787Q53398988-A7E366BF-37B3-4598-8361-1990C00F6D6CQ54268399-146B81CC-5DE2-462E-A14B-1FA803115DEAQ54326921-801753B5-7135-428B-BA43-C6A3384EA8E5Q54977227-F03A7A88-0141-4CF4-80D4-7D56BB5D240CQ55030400-ACEE2731-9579-4289-9D4E-9F7C0F269246Q55065364-7E0CFD72-0010-45E8-B049-D6780FF4AD0AQ55080593-EA233026-3965-4511-8F78-03E214F83E30Q55240544-84F62CC3-A947-4420-9BF1-6D10B4B1F722Q55311835-55781403-3AF6-4211-B358-2254724793B9Q56890107-E46FD390-A39A-46B0-B8FF-347A89F59458Q57072901-56CFF069-9338-4A46-B476-2301574B586EQ57247680-A45E8A5D-5210-4063-8007-B1BC1F978CBC
P2860
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation.
@en
type
label
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation.
@en
prefLabel
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation.
@en
P2093
P2860
P50
P1433
P1476
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation.
@en
P2093
Alejandro Torres-Hernandez
Antonina Avanzi
Constantinos Pantelis Zambirinis
Cristina Hajdu
Daniel Tippens
Donnele Daley
Elliot Newman
George Miller
Gregor Werba
Jung-Eun Jang
P2860
P304
1485-1499.e15
P356
10.1016/J.CELL.2016.07.046
P407
P577
2016-08-25T00:00:00Z